Alan R. Schwartz, MD
Dr. Schwartz has investigated mechanisms of sleep disordered breathing with a special emphasis on novel approaches to the diagnosis and management of this disorder. He is an author of approximately 175 articles and three patents, and is an established investigator with a 30+ year record of continuous NIH and industry sponsored research funding. He has mentored numerous post-doctoral trainees and junior faculty. His research activities have explored the mechanisms and impact of sleep disordered breathing across a broad range of clinical and societal outcomes.
Dr. Schwartz is currently engaged in NIH and industry sponsored research on neurostimulation treatment strategies for sleep disordered breathing. In interdisciplinary work, he collaborates extensively with colleagues at the University of Pennsylvania Perelman School of Medicine, where he is an Adjunct Professor of Otorhinolaryngology. In his role as scientific advisor, Dr. Schwartz has guided the research and development of novel diagnostic and therapeutic technologies in the sleep and breathing field for many years. Dr. Schwartz has successfully designed and executed pre-clinical, first-in-man, and clinical trials of medical devices and digital technologies. Dr. Schwartz has participated extensively in scientific advisory boards, FDA proceedings, and grants and manuscript review. He has developed and applied low- and high-tech solutions to sleep and breathing disorders for populations in both the developed and developing world.